Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

136 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Completed

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors

NCT01375842

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • HonorHealth Research Institute - Pima Center Scottsdale, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Stanford Univ Medical Center; Dept Central Pharmacy Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 21 locations
View Trial Details
Completed

Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

NCT00660920

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +14 more
Locations
  • ARIAD Investigational Site #075 San Francisco, California, United States
  • ARIAD Investigational Site #011 Ann Arbor, Michigan, United States
  • ARIAD Investigational Site #048 Portland, Oregon, United States
  • ARIAD Investigational Site #076 Nashville, Tennessee, United States
View Trial Details

Related conditions